Mortality risk score for patients with Chagas cardiomyopathy and pacemaker
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012114 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Giselle de Lima Peixoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil. Hauptthemen laut MEDLINE: Chagas Cardiomyopathy, Pacemaker, Artificial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Medtronic Company Brazil, Medtronic Brazil.
Abstract (Originalsprache)
Background
Prognosis of Chronic Chagasic Cardiomyopathy (CCC) patients depends on functional and clinical factors. Bradyarrhythmia requiring pacemaker is a common complication. Prognosis of these patients is poorly studied, and mortality risk factors are unknown. We aimed to identify predictors of death and to define a risk score for mortality in a large cohort of CCC patients with pacemaker.
Methods
It was an observational, unicentric and prospective study. The endpoint was all-cause mortality. Cox regression was used to identify predictors of death and to define a risk score. Bootstrapping method was used to internal score validation.
Results
We included 555 patients and after a mean follow-up of 3.7±1.5 years, 100 (18%) deaths occurred. Predictors of death were: right ventricular dysfunction (HR [hazard ratio] 2.24; 95%CI 1.41–3.53; P = 0.001); heart failure class III or IV (HR 2.16; 95% confidence interval [95%CI] 1.16–4.00; P = 0.014); renal disease (HR 2.14; 95%CI 1.24–3.68; P = 0.006); left ventricular end-systolic diameter > 44mm (HR 1.97; 95%CI 1.26–3.05; P = 0.003); atrial fibrillation (HR 1.94; 95%CI 1.25–2.99; P = 0.003) and cardiomegaly on X-ray (HR 1.87; 95%CI 1.10–3.17; P = 0.020). The score identified patients with: low (0–20 points), intermediate (21–30 points) and high risk (>31points). The optimism-corrected C-statistic of the predictive model was 0.751 (95% CI 0.696–0.806). Internal validation with bootstrapping revealed a calibration slope of 0.946 (95% CI 0.920–0.961), reflecting a small degree of over-optimism and C-statistic of 0.746 (95% CI 0.692–0.785).
Conclusions
This study identified predictors of mortality in CCC patients with pacemaker defining a simple, validated and specific risk score.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.
ORCID-Profile: Giselle de Lima Peixoto
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Medtronic Company Brazil
- Medtronic Brazil
Zitieren
APA
de Lima Peixoto, G., de Siqueira, S. F., Nishioka, S. A. D., Pedrosa, A. A. A., Teixeira, R. A., Costa, R., & Martinelli Filho, M. (2024). Mortality risk score for patients with Chagas cardiomyopathy and pacemaker. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012114
Vancouver
de Lima Peixoto G, de Siqueira SF, Nishioka SAD, Pedrosa AAA, Teixeira RA, Costa R, et al. Mortality risk score for patients with Chagas cardiomyopathy and pacemaker. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012114
BibTeX
@article{deLimaPeixoto2024,
author = {de Lima Peixoto, Giselle and de Siqueira, Sérgio Freitas and Nishioka, Silvana Angelina D'Orio and Pedrosa, Anísio Alexandre Andrade and Teixeira, Ricardo Alkmim and Costa, Roberto and Martinelli Filho, Martino},
title = {Mortality risk score for patients with Chagas cardiomyopathy and pacemaker},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012114}
}
EUVIMED